持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2024/11/15 | 日証協 | 226,000株 | +4.02% | 212,479株 | -51.45% | 197,276株 | -4.55% | 22,639株 | +25.8% |
2024/11/08 | 日証協 | 217,260株 | -24.3% | 437,682株 | +6.47% | 206,690株 | -8.38% | 17,996株 | -84.74% |
2024/11/01 | 日証協 | 287,013株 | +59.02% | 411,077株 | +18.58% | 225,590株 | +43.73% | 117,920株 | +1895.26% |
2024/10/25 | 日証協 | 180,491株 | -2.48% | 346,674株 | +157.47% | 156,955株 | -0.28% | 5,910株 | -70.25% |
2024/10/18 | 日証協 | 185,088株 | -1.85% | 134,644株 | -56.39% | 157,390株 | -12% | 19,865株 | +46.07% |
2024/10/11 | 日証協 | 188,572株 | +12.34% | 308,718株 | +25.21% | 178,855株 | +3.1% | 13,600株 | -73.04% |
2024/10/04 | 日証協 | 167,856株 | +142.24% | 246,559株 | +92.2% | 173,469株 | +7.52% | 50,450株 | -16.31% |
2024/09/27 | 日証協 | 69,294株 | -38.61% | 128,282株 | -44.62% | 161,334株 | +1.04% | 60,281株 | +21.04% |
2024/09/20 | 日証協 | 112,884株 | +26.51% | 231,626株 | +91.46% | 159,667株 | +29.66% | 49,804株 | +176.63% |
2024/09/13 | 日証協 | 89,232株 | +8.57% | 120,976株 | +25.67% | 123,142株 | -4.95% | 18,004株 | +49.29% |
2024/09/06 | 日証協 | 82,192株 | -31.48% | 96,268株 | -26.92% | 129,549株 | -23.16% | 12,060株 | -87.37% |
2024/08/30 | 日証協 | 119,958株 | -1.54% | 131,734株 | +0.01% | 168,599株 | +33.34% | 95,456株 | +2298.39% |
2024/08/23 | 日証協 | 121,832株 | -12.23% | 131,724株 | +2.99% | 126,447株 | -4.09% | 3,980株 | -56.64% |
2024/08/16 | 日証協 | 138,811株 | -8.92% | 127,902株 | +0.2% | 131,843株 | +0.14% | 9,179株 | -0.3% |
2024/08/09 | 日証協 | 152,401株 | -1.6% | 127,646株 | +1.39% | 131,658株 | -6.26% | 9,207株 | -19.94% |
2024/08/02 | 日証協 | 154,886株 | -0.35% | 125,900株 | -23.76% | 140,449株 | -12.62% | 11,500株 | -47% |
2024/07/26 | 日証協 | 155,424株 | -7.2% | 165,139株 | -27.55% | 160,742株 | -2.43% | 21,700株 | +53.87% |
2024/07/19 | 日証協 | 167,479株 | -17.19% | 227,927株 | +9.11% | 164,742株 | -20.2% | 14,103株 | +2.2% |
2024/07/12 | 日証協 | 202,237株 | -7.96% | 208,902株 | -33.1% | 206,436株 | -0.89% | 13,800株 | -65.09% |
※株式分割は考慮していませんのでご注意ください。
Page Top